Literature DB >> 18278215

Aspects of 6-[18F]fluoro-L-DOPA preparation. Deuterochloroform as a substitute solvent for Freon 11.

F Füchtner1, J Zessin, P Mäding, F Wüst.   

Abstract

AIM: Replacement of the ecologically harmful solvent Freon 11 (CFCl(3)) by chloroform for the module-assisted preparation of 6-[(18)F]fluoro-L-DOPA based on the electrophilic radiofluorodestannylation of the precursor N-formyl-3,4-di-tert-butoxycarbonyloxy-6-(trimethylstannyl)-L-phenylalanine ethyl ester. MATERIALS,
METHODS: The TRACERlab Fx FDOPA module (GE Medical Systems) was used for the preparation of 6-[(18)F]fluoro-L-DOPA. Cyclotron-produced [(18)F]F(2) gas (5 GBq) was passed through a cooled solution (5 degrees C) of the stannyl precursor (45 mg) in CDCl(3) (10 ml). After the [(18)F]fluorination step, HCl (2 ml, 6 mol/l) was added to the solution. Then the reaction mixture was heated at 80 degrees C for 5 min under vacuum to evaporate the chloroform. The hydrolysis to remove the protecting groups was completed by heating the closed reactor at 130 degrees C for 8 min. After cooling to 20 degrees C the reaction mixture was purified by HPLC with two polymer-based RP columns (PRP-1, 7 microm, 10 x 250 mm, Hamilton) using a solution of AcOH/AcONa (pH 4.7) as eluent. The 6-[(18)F]fluoro-L-DOPA fraction was collected and sterile filtrated.
RESULTS: Three types of stabilised chloroform were tested for the radiofluorination of the precursor. Only by use of deuterochloroform stabilised with silver no significant losses of radioactivity were observed. Thus, 6-[(18)F]fluoro-L-DOPA purified by HPLC was obtained in decay-corrected radiochemical yields of 25+/-3%, ready for human use.
CONCLUSION: CDCl(3) has proved to be a convenient solvent for the module-assisted preparation of 6-[(18)F]fluoro-L-DOPA. In this way the use of the polluting Freon 11 can be avoided.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18278215

Source DB:  PubMed          Journal:  Nuklearmedizin        ISSN: 0029-5566            Impact factor:   1.379


  7 in total

1.  One-pot synthesis of high molar activity 6-[18F]fluoro-l-DOPA by Cu-mediated fluorination of a BPin precursor.

Authors:  Andrew V Mossine; Sean S Tanzey; Allen F Brooks; Katarina J Makaravage; Naoko Ichiishi; Jason M Miller; Bradford D Henderson; Marc B Skaddan; Melanie S Sanford; Peter J H Scott
Journal:  Org Biomol Chem       Date:  2019-09-19       Impact factor: 3.876

2.  Comparison of dopamine turnover, dopamine influx constant and activity ratio of striatum and occipital brain with ¹⁸F-dopa brain PET in normal controls and patients with Parkinson's disease.

Authors:  Liane Oehme; Maria Perick; Bettina Beuthien-Baumann; Martin Wolz; Alexander Storch; Matthias Löhle; Birgit Herting; Jens Langner; Jörg van den Hoff; Heinz Reichmann; Jörg Kotzerke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-07       Impact factor: 9.236

3.  Synthesis of high-molar-activity [18F]6-fluoro-L-DOPA suitable for human use via Cu-mediated fluorination of a BPin precursor.

Authors:  Andrew V Mossine; Sean S Tanzey; Allen F Brooks; Katarina J Makaravage; Naoko Ichiishi; Jason M Miller; Bradford D Henderson; Thomas Erhard; Christian Bruetting; Marc B Skaddan; Melanie S Sanford; Peter J H Scott
Journal:  Nat Protoc       Date:  2020-04-08       Impact factor: 13.491

Review 4.  6-[18F]fluoro-L-DOPA: a well-established neurotracer with expanding application spectrum and strongly improved radiosyntheses.

Authors:  M Pretze; C Wängler; B Wängler
Journal:  Biomed Res Int       Date:  2014-05-28       Impact factor: 3.411

5.  Comparison of 6-[18F]FDOPA PET with Nigrosome 1 detection in patients with parkinsonism.

Authors:  Enrico Michler; Daniel Kaiser; Kiriaki Eleftheriadou; Björn Falkenburger; Jörg Kotzerke; Sebastian Hoberück
Journal:  EJNMMI Res       Date:  2021-02-15       Impact factor: 3.138

6.  Single cocaine exposure does not alter striatal pre-synaptic dopamine function in mice: an [18 F]-FDOPA PET study.

Authors:  David R Bonsall; Michelle Kokkinou; Mattia Veronese; Christopher Coello; Lisa A Wells; Oliver D Howes
Journal:  J Neurochem       Date:  2017-10-26       Impact factor: 5.372

7.  Identification of Nanobodies against the Acute Myeloid Leukemia Marker CD33.

Authors:  Ema Romão; Ahmet Krasniqi; Laila Maes; Camille Vandenbrande; Yann G-J Sterckx; Benoit Stijlemans; Cécile Vincke; Nick Devoogdt; Serge Muyldermans
Journal:  Int J Mol Sci       Date:  2020-01-02       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.